更多肾衰竭患者应将治疗带回家吗？我们从新冠疫情中学到了什么。
Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19.
作者信息
Yu Xueqing, Jha Vivekanand, Nakamoto Hidetomo
机构信息
Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong, China.
The George Institute for Global Health, University of New South Wales, New Delhi, India.
出版信息
Kidney Dis (Basel). 2022 Jun 15;8(5):357-367. doi: 10.1159/000525046. eCollection 2022 Nov.
BACKGROUND
The COVID-19 pandemic is challenging healthcare systems worldwide and has placed hospitals and healthcare providers (HCPs) at the center of a global crisis. Disruptions to hospital priorities, and limitations placed on the mobility of societies, have contributed to changes in the way HCPs and patients view and access dialysis for kidney failure, including which dialysis modality is preferred.
SUMMARY
This article explores the dialysis experience within the COVID-19 pandemic environment in the Asia Pacific region and presents evidence that peritoneal dialysis (PD) provides benefits to patients, HCPs, and health systems. As the number of people infected with COVID-19 has increased, the advantages of PD as a dialysis modality for limiting the spread of COVID-19 infection has been recognized.
KEY MESSAGE
The utility of PD has been demonstrated during the COVID-19 pandemic; thus, ensuring that the usage of PD is maintained and increased in a post-pandemic future is key. Such a scenario could enhance our ability to care for patients without interruption in circumstances of unforeseen obstacles and supports the ability of healthcare systems and patients to overcome barriers to dialysis access.
背景
新冠疫情给全球医疗系统带来挑战，使医院和医护人员置身于一场全球危机的中心。医院工作重点的打乱以及社会流动性的限制，导致医护人员和患者看待及获取肾衰竭透析治疗的方式发生了变化，包括对首选透析方式的看法。
总结
本文探讨了亚太地区新冠疫情环境下的透析经历，并提供证据表明腹膜透析（PD）对患者、医护人员和卫生系统都有益处。随着新冠病毒感染者数量的增加，腹膜透析作为一种限制新冠病毒感染传播的透析方式的优势已得到认可。
关键信息
腹膜透析在新冠疫情期间的效用已得到证明；因此，在疫情后的未来确保维持并增加腹膜透析的使用至关重要。这种情况可以增强我们在遇到不可预见的障碍时不间断地照顾患者的能力，并支持医疗系统和患者克服透析治疗获取障碍的能力。
Zotero 插件